Volume 15, Issue 2, June 2026

  • Research Article

    Antifibrotic Therapy in the Treatment of Patients with Pulmonary Manifestations in Complicated COVID-19

    Mukhamadieva Lyaysan Ramilevna*, Mavzyutova Guzel Anvarovna, Mirsaeva Gulchagra Khanifovna, Aleksandrovich Natalia Victorovna, Ibragimova Anna Aleksandrovna, Galieva Guzel Akhmetovna, Amirova Guzel Fanisovna, Mavziutova Alsu Airatovna, Gayanova Maya Marsovna, Umutbaev Salavat Vilsamovich

    Issue: Volume 15, Issue 2, June 2026
    Pages: 16-20
    Received: 5 March 2026
    Accepted: 17 April 2026
    Published: 16 May 2026
    DOI: 10.11648/j.sjcm.20261502.13
    Downloads:
    Views:
    Abstract: The study assessed the efficacy and safety of Longidaza® (bovhyaluronidase azoximer, 3000 IU) in patients with lung damage after complicated COVID‑19. Two groups of 30 patients each were compared: the first received Longidaza® via intramuscular injections (3000 IU every five days, 15 injections total); the second was under dynamic observation witho... Show More